CELL SIGNALING TECHNOLOGY search Cell Signaling Technology BCL2 products
includes other brands or spellings
|
| wb | | Cell Signaling anti-Bcl-2 antibody was used in western blot to study the effect of adrenomedullin on myocardial infarction and apoptosis after ischemia and reperfusion. |
| wb | | Cell Signaling Technology anti-Bcl-2 antibody was used in western blot to detect Bcl-2 in U373 cells with human MEKK3 stable transfection. |
| wb | | Cell Signaling rabbit anti-phospho-Bcl-2 antibody was used in western blot to detect phospho-Bcl-2 in human ejaculate spermatozoa. |
| wb | | Cell Signaling Technology anti-Bcl-2 antibody was used in western blot to study the relationship between FPR expression and the biologic behavior of glioma cells. |
| wb | | Cell Signaling Bcl-2 antibody was used in western blot to study apoptotic cell death in prostate cancer caused by androgen receptor silencing. |
SIGMA-ALDRICH search Sigma-Aldrich BCL2 products
includes other brands or spellings
|
| wb | | Sigma anti-Bcl-2 antibody was used in western blot to detect Bcl-2 in BdGBM cells. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology BCL2 products
includes other brands or spellings
|
| ip, wb | | Santa Cruz Biotechnology anti-Bcl-2 antibody was used in human PC-3 cells and in western blot and immunoprecipitation to study the role of IGFBP-3 for TNF- -induced apoptosis. |
| wb | | Santa Cruz Biotechnology polyclonal N19 Bcl2 antibody was used in western blot to study cell death protection by cytosolic prion protein in human primary neurons. |
| wb | | Santa Cruz Biotechnology anti-BCL-2 antibody was used in western blot to study that PIM-2 kinase phosphorylates BAD on Serine 112 and reverses BAD-induced cell death. |
| wb | | Santa Cruz Biotechnology mouse anti-bcl-2 antibody was used in western blot to provide another molecular mechanism consistent with the hypothesis that 15-LOX-1 may exert anti-inflammatory effects by inhibiting TrxR. |
| wb | | Santa Cruz Biotechnology anti-Bcl-2 antibody SC-7382 was used in western blot to study the effect of p53-independent NOXA induction on apoptotic resistance of malignant melanomas. |
| wb | | Santa Cruz Biotechnology mouse monoclonal anti-Bcl-2 antibody sc-7382 was used in western blot to study the expression of proapoptotic factor Nix and Bcl-xL during terminal erythroid differentiation. |
| wb | | Santa Cruz Biotechnology mouse anti-human Bcl-2 antibody was used in western blot to detect Bcl-2 in LNCaP and PC-3 cells. |
| wb | | Santa Cruz Biotechnology anti-Bcl-2 antibody was used in western blot to detect Bcl-2 in wild-type Jurkat and Jurkat cells stably transfected with Bcl-2 or vector control cells. |
| wb | | Santa Cruz Biotechnology mouse monoclonal anti-Bcl2 antibody Bcl-2 was used in human T-cell lymphoblastic leukemia cell line CCRF-HSB-2 cells and in western blot to study the taxol-induced caspase-10-dependent apoptosis. |
| wb | | Santa Cruz Biotechnology mouse monoclonal anti-Bcl-2 antibody was used in western blot to detect Bcl-2 in MCF-7 cells treated with drugs. |
| wb | | Santa Cruz Biotechnology Bcl-2 antibody was used in western blot to study apoptotic induction by apicidin in human Bcr-Abl-positive leukemia cells. |
| wb | | Santa Cruz Biotechnology polyclonal anti-Bcl-2 antibody was used in western blot to detect Bcl-2 in Jurkat cells treated with phytosphingosine. |
| wb | | Santa Cruz Biotechnology anti-Bcl-2 antibody was used in human Jurkat cells and in western blot to study the effect of granzyme B on Mcl-1. |
| wb | | Santa Cruz anti-Bcl-2 antibody was used in western blot to study the functional link between FGFR2 signaling and Cbl-mediated alpha-5-integrin expression resulting in altered cell attachment and apoptosis in osteoblasts. |
| wb | | Santa Cruz Biotechnology mouse anti-BCL-2 antibody was used in western blot to study the CSF-independent human macrophages survival. |
| wb | | Santa Cruz Biotechnology Bcl-2 antibody was used in western blot to study the role of Cyr61 in endometrial tumorigenesis. |
| wb | | Santa Cruz Biotechnology mouse monoclonal anti-Bcl-2 (100) antibody was used in western blot to study the selective induction of apoptosis by synthetic retinoid CD437 in human lung cancer cells. |
| wb | | SCBT anti-Bcl-2 antibody was used in western blot to study the induction of neuroblastoma cell apoptosis by TrkA. |
| wb | | SCBT Bcl-2 antibody was used in western blot to study the effect of Gadd45a on Bim. |
| wb | | Santa Cruz Biotechnology monoclonal antibody which recognizes Bcl-2 was used in western blot to study the functions of human SCO1 and SCO2 in copper delivery to cytochrome c oxidase. |
| wb | | Santa Cruz Biotechnology monoclonal Bcl-2 antibody was used in western blot to study the effect on BAD phosphorylation and Bcl-2 association by Raf-1 phosphorylation. |
R & D SYSTEMS search R & D Systems BCL2 products
includes other brands or spellings
|
| flow, wb | | R&D Bcl-2 and phospho-Bcl-2 serine 70 antibodies were used in western blot and flow cytometry to study Bcl-2 rescues of mitochondrial apoptosis. |
BD BIOSCIENCES search BD Biosciences BCL2 products
includes other brands or spellings
|
| flow | | BD Biosciences FITC-anti-bcl-2 monoclonal antibody was used in flow cytometry to study a 10-aa-long sequence in SLP-76 upstream of the Gads binding site which is essential for T cell development and function. |
| ic | | BD PharMingen monoclonal anti-bcl-2 antibody was used in human islets and in immunocytochemistry to study the capability of GLP-1 to preserve viability and function of freshly isolated human islets. |
| ih, wb | | BD Transduction Laboratories monoclonal antibody to Bcl-2 was used in western blot in the study of fibronectin protecting prostate cancer cells from tumor necrosis factor-alpha-induced aoptosis via the AKT/Survivin pathway. |
| wb | | BD Transduction Bcl-2 antibody was tested in western blot by Abminer. |
| wb | | BD Biosciences anti-Bcl-2 antibody was used in western blot to study the effects of TL1A-induced NF- B and c-IAP2 on DR3-mediated apoptosis in TF-1 cells. |
| wb | | BD Biosciences anti-Bcl-2 antibody was used in western blot to study the function of protein phosphatase subunit G5PR in B cell receptor–induced apoptosis. |
| wb | | PharMingen monoclonal anti-Bcl-2 antibody was used in western blot to study NADUO as an ischemia/reperfusion-regulated gene in cardiomyocytes. |
| wb | | BD PharMingen anti–bcl-2 was used in western blot to detect bcl-2 in Jurkat cells. |
| wb | | Pharmingen antihuman Bcl-2 antibody was used in western blot to study the different antiapoptotic pathways between wild-type and mutated FLT3. |
| wb | | Becton Dickinson mouse anti-Bcl-2 antibody was used in western blot to study 7-Kchol induces oxidative stress and apoptotic events in human aortic smooth muscle cells. |
| wb | | Transduction Labs mouse monoclonal anti-Bcl-2 antibody was used in western blot to study the possible correlation of the antitumor activity of fibroblast growth factors (FGFs) for medulloblastoma with FGF receptor expression and tumor variant. |
MILLIPORE search Millipore BCL2 products
includes other brands or spellings
|
| wb | | Upstate Biotechnologies anti-Bcl-2 antibody was used in western blot to study dendritic cell apoptosis in the maintenance of immune tolerance. |
INVITROGEN search Invitrogen BCL2 products
includes other brands or spellings
|
| wb | | BIOSOURCE International anti-Bcl-2 antibody was used in western blot to study the functional expression of the interleukin-11 receptor alpha-Chain and evidence of antiapoptotic effects in human colonic epithelial cells. |
THERMO FISHER SCIENTIFIC search Thermo Fisher Scientific BCL2 products
includes other brands or spellings
|
| wb | | Lab Vision bcl-2alpha antibody was tested in western blot by Abminer. |
| wb | | NeoMarkers anti-Bcl-2 antibody was used in human T-cell leukemia cell lines and in western blot to study the effect of Jak-Stat pathway on cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. |
BECKMAN COULTER search Beckman Coulter BCL2 products
includes other brands or spellings
|
| flow, wb | | DAKO mouse anti-human Bcl-2 antibody was used in western blot and flow cytometry to analyze the expression of Bcl-2 in high density, CD27-depleted tonsil B lymphocytes and lysates of CD40-activated human follicular B cells from human tonsil tissue of 3- to 15-year-old donors. |
| ic | | DakoCytomation mouse monoclonal FITC-conjugated anti–Bcl-2 antibody was used in immunocytochemistry to study interleukin 7 effects on T cell acute lymphoblastic leukemia cells. |
| ih | | DakoCytomation BCL2 antibody was tested in immunohistochemistry by HPA (CAB000003) . |
| ih | | Dako antibody against BCL2 was used in immunohistochemistry to identify the human germinal center-associated lymphoma (HGAL) in gene-expression profiling studies of diffuse large B-cell lymphoma (DLBCL). |
| ih | | DAKO anti-bcl-2 antibody was used in immunohistochemistry to study the tissue microarray validation of Epidermal Growth Factor Receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology. |
| ih | | DAKO anti-bcl-2 antibody clone 124 was used in paraffin sections from human urothelial bladder carcinomas and in immunohistochemistry to study the role of TIMP-2 in human urothelial cancer. |
| ih | | DAKO monoclonal Bcl-2 antibody (clone 124) was used in immunohistochemistry to detect Bcl-2 expression in human primary mediastinal (thymic) B-cell lymphoma (PMBL). |
| ih | | DAKO anti-BclII antibody was used in immunohistochemistry to detect BclII in normal lung, benign lesions, preinvasive lesions, low-grade tumors and invasive lung carcinoma. |
| ih | | Dako anti-Bcl-2 antibody (124) was used in immunohistochemistry to study the implications of expression of a panel of oncogenic proteins (Bcl-2, Bcl-6, and c-Myc) and p53 for predicting clinical outcome, particularly overall survival, in immunocompetent individuals with primary CNS DLBCL. |
| ih | | DAKO bcl-2 antibody (clone 124) was used in immunohistochemistry to study the upregulated hypoxia inducible factor-1α and -2α pathway in rheumatoid arthritis and osteoarthritis. |
| ih | | DAKO mouse monoclonal antihuman Bcl-2 antibody was used in immunohistochemistry to study the possible spatial and temporal relationships among GATA-6 expression, cell proliferation, apoptosis, and the apoptosis-related proteins Bcl-2 and Bax during human fetal testicular development. |
| wb | | Dako mouse monoclonal anti-Bcl-2 antibody was used in western blot to study the mechanism by which the EBNA3 proteins gain access to the antigen-processing pathways in infected cells although they were degraded by purified 20S proteasomes in vitro. |
| wb | | DAKO anti-Bcl-2 antibody M0887 was used in human HeLa cells and in western blot to study the role of CDIR for apoptosis. |
| wb | | DAKO anti-Bcl-2 antibody was used in western blot to detect Bcl-2 in U937 cells incubated for 24 h with 1-mM SB or 2-µM SAHA ± 100-ng/ml TRAIL in the absence or presence of the pan-caspase inhibitor BOC-D-fmk. |
| wb | | Dako mouse monoclonal anti-Bcl-2 antibody was used in western blot to detect Bcl-2 in K562-R, LAMA-R and their parental counterparts. |
| wb | | DAKO mouse anti-human Bcl2 (clone 124, M0887) was used in western blot to study the suppression of p53 and c-myc and regulation of apopotosis by fibronectin in human primary cells. |
| wb | | Dako mouse monoclonal Bcl-2 antibody was used in western blot to study the interactions between pharmacological MEK1/2 inhibitors and STI571 in Bcr/Abl-positive human leukemia cells. |
BEIJING ZHONGSHAN BIOLOGICAL TECHNOLOGY
|
| ih | | Beijing Zhongshan Biological Technology mouse monoclonal bcl-2 antibody was used in immunohistochemistry to study gastrin, somatostatin, bcl-2, and bax expression in large intestine carcinoma. |
CAMBRIDGE RESEARCH BIOCHEMICALS
|
| ih | | Cambridge Research Biochemicals monoclonal anti-human Bcl-2 antibody was used in immunohistochemistry to detect Bcl-2 protein in transgenic mice overexpressing human Bcl-2. |
CN BIOSCIENCES
|
| wb | | CN Biosciences anti-Bcl-2 antibody was used in western blot to study the induction a Fas-associated death domain-dependent type II apoptotic pathway by tissue inhibitor of metalloproteinase-3. |
WAKO PURE CHEMICAL INDUSTRIES
|
| wb | | Wako Pure Chemical Industries monoclonal anti-human Bcl-2 antibody was used in western blot to study the involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis which was induced by β-hydroxyisovalerylshikonin. |
Articles Reviewed |
| 1. Yvonne L Kapila et al. The heparin-binding domain and V region of fibronectin regulate apoptosis by suppression of p53 and c-myc in human primary cells. 2002 |
| 2. Chunrong Yu et al. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells. 2002 |
| 3. Sabine M Duplan et al. Antitumor activity of fibroblast growth factors (FGFs) for medulloblastoma may correlate with FGF receptor expression and tumor variant. 2002 |
| 4. Mark Bond et al. Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway. 2002 |
| 5. Shi-Yong Sun et al. The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells. 2002 |
| 6. Roopmathy Rajah et al. Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: role of Bcl-2 phosphorylation. 2002 |
| 7. Ksenya Shchors et al. Cell death inhibiting RNA (CDIR) derived from a 3'-untranslated region binds AUF1 and heat shock protein 27. 2002 |
| 8. Makoto Kamachi et al. Human autoimmune sera as molecular probes for the identification of an autoantigen kinase signaling pathway. 2002 |
| 9. Stefano A Pileri et al. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. 2003 |
| 10. Chung-Che Chang et al. Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals. 2003 |
| 11. Wulin Aerbajinai et al. The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation. 2003 |
| 12. Ilkka Ketola et al. Transcription factor GATA-6, cell proliferation, apoptosis, and apoptosis-related proteins Bcl-2 and Bax in human fetal testis. 2003 |
| 13. Chih-Cheng Yang et al. Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells. 2003 |
| 14. Kazuo Kato et al. Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. 2003 |
| 15. Pierre-François Cartron et al. Nonredundant role of Bax and Bak in Bid-mediated apoptosis. 2003 |
| 16. Alexandra Giatromanolaki et al. Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. 2003 |
| 17. Yosuke Minami et al. Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemia. 2003 |
| 18. Leng Wen et al. TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells. 2003 |
| 19. Xavier Roucou et al. Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. 2003 |
| 20. Bin Yan et al. The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death. 2003 |
| 21. Loredana Farilla et al. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. 2003 |
| 22. Torsten O Nielsen et al. Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology. 2003 |
| 23. Moon-Taek Park et al. Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells. 2003 |
| 24. Mara Fornaro et al. Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway. 2003 |
| 25. MarĂa Victoria Sánchez-GĂłmez et al. Caspase-dependent and caspase-independent oligodendrocyte death mediated by AMPA and kainate receptors. 2003 |
| 26. June-Won Cheong et al. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. 2003 |
| 27. Patricia K A Mongini et al. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis. 2003 |
| 28. Hariklia Gakiopoulou et al. Tissue inhibitor of metalloproteinase-2 as a multifunctional molecule of which the expression is associated with adverse prognosis of patients with urothelial bladder carcinomas. 2003 |
| 29. Ajoy K Samanta et al. Overexpression of MEKK3 confers resistance to apoptosis through activation of NFkappaB. 2004 |
| 30. Stephan Kiessling et al. Functional expression of the interleukin-11 receptor alpha-chain and evidence of antiapoptotic effects in human colonic epithelial cells. 2004 |
| 31. Roberto R Rosato et al. Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells. 2003 |
| 32. Chi-Hsiao Yeh et al. Differential-display polymerase chain reaction identifies nicotinamide adenine dinucleotide-ubiquinone oxidoreductase as an ischemia/reperfusion-regulated gene in cardiomyocytes. 2004 |
| 33. Alberto Ballestrero et al. Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 2004 |
| 34. Saveria Aquila et al. Estrogen receptor (ER)alpha and ER beta are both expressed in human ejaculated spermatozoa: evidence of their direct interaction with phosphatidylinositol-3-OH kinase/Akt pathway. 2004 |
| 35. Jie Han et al. Degradation of Mcl-1 by granzyme B: implications for Bim-mediated mitochondrial apoptotic events. 2004 |
| 36. Julien Mazieres et al. Loss of RhoB expression in human lung cancer progression. 2004 |
| 37. Margaret K Yu et al. Conditional expression of 15-lipoxygenase-1 inhibits the selenoenzyme thioredoxin reductase: modulation of selenoproteins by lipoxygenase enzymes. 2004 |
| 38. Daniel Broderick Longley et al. The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites. 2004 |
| 39. Yun Dai et al. A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2. 2004 |
| 40. Scot C Leary et al. Human SCO1 and SCO2 have independent, cooperative functions in copper delivery to cytochrome c oxidase. 2004 |
| 41. Yutaka Masuda et al. Involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by beta-hydroxyisovalerylshikonin. 2004 |
| 42. Jian-Zhong Qin et al. p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas. 2004 |
| 43. Joao T Barata et al. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. 2004 |
| 44. Soo-Jung Park et al. Taxol induces caspase-10-dependent apoptosis. 2004 |
| 45. Wenwen Chien et al. Cyr61 suppresses growth of human endometrial cancer cells. 2004 |
| 46. Eric Pedruzzi et al. NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. 2004 |
| 47. Jia-Ding Mao et al. Correlation between expression of gastrin, somatostatin and cell apoptosis regulation gene bcl-2/bax in large intestine carcinoma. 2005 |
| 48. Yasodha Natkunam et al. Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. 2005 |
| 49. Karim Kaabeche et al. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation. 2005 |
| 50. Chiou-Feng Lin et al. Bcl-2 rescues ceramide- and etoposide-induced mitochondrial apoptosis through blockage of caspase-2 activation. 2005 |
| 51. Xinbo Liao et al. Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. 2005 |
| 52. Robert Touitou et al. Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells. 2005 |
| 53. Shenghao Jin et al. p21-activated Kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association. 2005 |
| 54. Tong Tong et al. Gadd45a expression induces Bim dissociation from the cytoskeleton and translocation to mitochondria. 2005 |
| 55. Ye Zhou et al. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. 2005 |
| 56. Jean-François Lavoie et al. TrkA induces apoptosis of neuroblastoma cells and does so via a p53-dependent mechanism. 2005 |
| 57. Yan Xing et al. Protein phosphatase subunit G5PR is needed for inhibition of B cell receptor-induced apoptosis. 2005 |
| 58. Iwao Komuro et al. Catalase plays a critical role in the CSF-independent survival of human macrophages via regulation of the expression of BCL-2 family. 2005 |
| 59. Lalit Kumar et al. A 10-aa-long sequence in SLP-76 upstream of the Gads binding site is essential for T cell development and function. 2005 |
| 60. Min Chen et al. Dendritic cell apoptosis in the maintenance of immune tolerance. 2006 |
| 61. Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |
| 62. Mariko Tomita et al. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. 2006 |
| 63. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |